NOVO.B.DK

309.6

+3.81%↑

GMAB.DK

1,987

-1.34%↓

HLUNB.DK

44.12

+0.73%↑

ZEAL.DK

510.6

+0.87%↑

NOVO.B.DK

309.6

+3.81%↑

GMAB.DK

1,987

-1.34%↓

HLUNB.DK

44.12

+0.73%↑

ZEAL.DK

510.6

+0.87%↑

NOVO.B.DK

309.6

+3.81%↑

GMAB.DK

1,987

-1.34%↓

HLUNB.DK

44.12

+0.73%↑

ZEAL.DK

510.6

+0.87%↑

NOVO.B.DK

309.6

+3.81%↑

GMAB.DK

1,987

-1.34%↓

HLUNB.DK

44.12

+0.73%↑

ZEAL.DK

510.6

+0.87%↑

NOVO.B.DK

309.6

+3.81%↑

GMAB.DK

1,987

-1.34%↓

HLUNB.DK

44.12

+0.73%↑

ZEAL.DK

510.6

+0.87%↑

Search

Coloplast A-S (Class B)

Fermé

562 -0.85

Résumé

Variation du prix de l'action

24h

Actuel

Min

555

Max

565.4

Chiffres clés

By Trading Economics

Revenu

-107M

805M

Ventes

28M

7B

P/E

Moyenne du Secteur

34.765

77.671

BPA

3.88

Rendement du dividende

3.96

Marge bénéficiaire

11.569

Employés

16,744

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.96%

2.35%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-10B

127B

Ouverture précédente

562.85

Clôture précédente

562

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 déc. 2025, 22:02 UTC

Résultats

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 déc. 2025, 21:46 UTC

Résultats

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 déc. 2025, 23:52 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 déc. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 déc. 2025, 23:20 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 déc. 2025, 23:15 UTC

Résultats

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 déc. 2025, 22:59 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 déc. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 déc. 2025, 22:40 UTC

Résultats

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 déc. 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 22:06 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 déc. 2025, 22:02 UTC

Résultats

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 déc. 2025, 22:00 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 déc. 2025, 21:53 UTC

Résultats

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 déc. 2025, 21:50 UTC

Acquisitions, Fusions, Rachats

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 déc. 2025, 21:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

10 déc. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 déc. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 déc. 2025, 21:45 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 21:33 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 déc. 2025, 21:32 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 déc. 2025, 21:28 UTC

Acquisitions, Fusions, Rachats

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 déc. 2025, 21:25 UTC

Résultats

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 déc. 2025, 21:18 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 déc. 2025, 21:16 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 déc. 2025, 21:15 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 déc. 2025, 21:15 UTC

Résultats

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 déc. 2025, 21:14 UTC

Résultats

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 déc. 2025, 21:14 UTC

Résultats

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat